The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies

Feasibility studies are an important component of preparations for efficacy field trials of vaccine candidates, but represent a neglected area in clinical trial literature. These studies are designed to identify cohorts of higher-risk individuals with sufficiently high incidence to support a vaccine...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2005-02, Vol.23 (12), p.1437-1445
Main Authors: Suligoi, Barbara, Wagner, Theresa M., Ciccozzi, Massimo, Rezza, Giovanni
Format: Article
Language:English
Subjects:
AIDS Vaccines
Applied microbiology
Biological and medical sciences
Epidemiology
Feasibility Studies
Fundamental and applied biological sciences. Psychology
HIV
HIV Infections - epidemiology
HIV Infections - prevention & control
HPV
HSV
Human immunodeficiency virus
Human papillomavirus
Humans
Methods
Microbiology
Miscellaneous
Prevention
Risk assessment
Risk reduction
Risk taking
Sexually transmitted diseases
Sexually Transmitted Diseases - epidemiology
Sexually Transmitted Diseases - prevention & control
STD
STI
Vaccine
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Viral Vaccines - immunology
Viral Vaccines - therapeutic use
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Feasibility studies are an important component of preparations for efficacy field trials of vaccine candidates, but represent a neglected area in clinical trial literature. These studies are designed to identify cohorts of higher-risk individuals with sufficiently high incidence to support a vaccine trial; to determine the readiness of these individuals to participate in a trial; to develop cost-effective recruitment and retention strategies, educational methods that ensure ethical informed consent, and instruments that accurately assess risk behaviours; to measure incidence rates over time and the effect of risk reduction interventions on incidence; to contribute estimates of incidence and loss to follow-up rates to sample size calculations; to assess the level of acceptability of a future efficacious vaccine in the target population and, in the case of several viruses, to identify circulating subtypes. Feasibility study methods have been largely developed in the context of HIV, but may also be used in the preparation of preventive intervention trials for other STI.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2004.10.002